Matrix Trust Company’s Arrowhead Research ARWR Stock Holding History

Matrix Trust Company’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100	Closed	-$6K	–	110
2026 Q1	$6K	Sell	100 -101	-50%	-$6.39K	﹤0.01%	176
2025 Q4	$13K	Buy	+201	New	+$9.85K	﹤0.01%	188

Other funds holding ARWR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Matrix Trust Company's ARWR Position: Q2 2026 in Review

Matrix Trust Company sold out of Arrowhead Research (ARWR) in Q2 2026, closing a stake of 100 shares — an estimated $6K sold.

Matrix Trust Company first reported a position in ARWR in Q4 2025 and held it in 2 quarters. The position peaked at $13K in Q4 2025. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

Matrix Trust Company reported no remaining Arrowhead Research position as of Q2 2026 after selling out during the quarter.
Matrix Trust Company sold 100 Arrowhead Research shares in Q2 2026, an estimated $6K.
Matrix Trust Company first reported a position in Arrowhead Research in Q4 2025 and held it in 2 quarters.
Matrix Trust Company's Arrowhead Research position peaked at $13K in Q4 2025.
500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Matrix Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.